FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Instagram Outage Disrupts Thousands of U.S. Users 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
FOSTER CITY, Calif., Feb. 28, 2017 -- TeraRecon (www.terarecon.com), a leader in advanced visualization and enterprise medical image viewing solutions, has selected to participate in the new UK NHS Supply Chain Framework. The NHS Supply Chain provides high-quality, cost-effective, and patient-focused healthcare products and supply chain services to the UK’s National Health Service (NHS), including hundreds of NHS trusts and healthcare organizations.
“The UK is emerging as a very exciting and innovative market for us, and we are excited to announce our participation in the NHS Supply Chain Framework. We are seeing a deep commitment and openness to more pure-play solutions that better position NHS hospitals for the rapidly changing healthcare IT landscape,” said Maria Proud-Levitas, UK Regional Sales Manager. Maria continued, “We work across the entire enterprise to offer a single viewing platform to serve the many various specialties requiring advanced tools for image review. Advanced visualization is at our core and is the reason we are being selected by our customers to consolidate on one platform and plan for the future.”
TeraRecon provides a full medical image viewing platform, including their industry leading advanced visualization, universal viewing, Overlay PACS™ viewing, as well as new holography and 3D Printing solutions. With deep roots in multi-specialty clinical tools, TeraRecon has been helping UK customers achieve their viewing and infrastructure goals in the UK since 2002.
About TeraRecon (www.terarecon.com)
TeraRecon is the largest independent, vendor neutral medical image viewing solution provider with a focus on advanced image processing innovation. TeraRecon iNtuition™ and iNteract+ solutions advance the accessibility, performance, clinical functionality and medical imaging workflow throughout many areas of the healthcare ecosystem. The company provides world class advanced visualization 3D post-processing tools, as well as a spectrum of enterprise medical image viewing, diagnostic interpretation, image sharing, cloud, interoperability and collaboration solutions. TeraRecon is a privately-held company with its world headquarters in Foster City, California with major offices in Frankfurt, Germany; Tokyo, Japan; Acton, MA, and Durham, NC.
Press Inquiries: TeraRecon US: 1-650-372-1100 | [email protected]
